(Q36492892)

English

Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

7

object named as

Caryn Lerman

1 reference

Europe PubMed Central

14 August 2017

PMC publication ID

4

object named as

Raymond Niaura

1 reference

Europe PubMed Central

14 August 2017

PMC publication ID

8

object named as

E Paul Wileyto

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Leonard H Epstein

2

object named as

Leonard Epstein

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

5

object named as

Larry Hawk

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Robert A Schnoll

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Janet Audrain

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Peter G Shields

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

27 June 2007

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Journal of Substance Abuse Treatment

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

34

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

234-241

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Pharmacotherapy for nicotine dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

Antidepressants for smoking cessation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

Placebo effects of tobacco smoking and other nicotine intake

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

Effect of nicotine on the tobacco withdrawal syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

Contributions from psychology to the study of drinking and driving

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

Development and validation of brief measures of positive and negative affect: The PANAS scales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

30 September 2017

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Effect of bupropion on depression symptoms in a smoking cessation clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Bupropion for smoking cessation: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Do small lapses predict relapse to smoking behavior under bupropion treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Changes in food reward following smoking cessation: a pharmacogenetic investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Assessment of blinding in clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Pharmacogenetic investigation of smoking cessation treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Biochemical verification of tobacco use and cessation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Self-reported abstinence effects in the first month after smoking cessation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Smoking withdrawal dynamics in unaided quitters.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266050

21 September 2018

Extended treatment with bupropion SR for cigarette smoking cessation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17600649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JSAT.2007.04.004

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36492892&oldid=1858323967"